Glimitoss MP 1mg/500mg/15mg Tablet SR
Marketer
Minitoss Medicines
Salt Composition
Glimepiride (1mg) + Metformin (500mg) + Pioglitazone (15mg)
Overview Glimitoss MP 1mg/500mg/15mg Tablet SR
Glimepiride/Metformin/Pioglitazone extended-release tablets (1mg/500mg/15mg) manage blood glucose in adults with type 2 diabetes. This combination medication complements diet and exercise to enhance glycemic control. It improves insulin effectiveness, reducing blood sugar. Follow your physician's prescribed dosage and regimen; take with food to prevent digestive discomfort. If a dose is missed, take it promptly unless the next dose is imminent; avoid doubling doses. Overdosage can cause hypoglycemia. Concurrent use with other diabetes medications, alcohol, or missed meals increases hypoglycemia risk; regular blood sugar monitoring is crucial. Common side effects include nausea, diarrhea, abdominal pain, headache, bone fractures, and respiratory infections. Prior to commencing treatment, disclose any kidney, liver, or heart conditions to your doctor. Pregnant or lactating individuals should seek medical advice before use. Kidney function tests will be performed before treatment begins. Limit alcohol consumption as it may exacerbate side effects.
Primary Ingredients of Glimitoss MP 1mg/500mg/15mg Tablet SR
No information provided. Please provide the text you wish me to rephrase.
Uses of Glimitoss MP 1mg/500mg/15mg Tablet SR
Managing type 2 diabetes
Major Benefits of Glimitoss MP 1mg/500mg/15mg Tablet SR:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Glimitoss MP 1mg/500mg/15mg Tablet SR whole; avoid chewing, crushing, or breaking it. Administer this extended-release tablet with a meal.
Common Side effects of Glimitoss MP 1mg/500mg/15mg Tablet SR:
- Hypoglycemia (low blood glucose level)
- Headache
- Nausea
- Diarrhea
- Dizziness
- Vomiting
- Anemia (low number of red blood cells)
- Weakness
- Sinus infection
How to use Glimitoss MP 1mg/500mg/15mg Tablet SR:
Follow your doctor's instructions precisely regarding dosage and treatment length for Glimitoss MP 1mg/500mg/15mg Tablet SR. Ingest the tablet whole; avoid chewing, crushing, or breaking it. Administer this medication with a meal.
How Glimitoss MP 1mg/500mg/15mg Tablet SR works:
Glimitoss MP 1mg/500mg/15mg Extended-Release tablets combine glimepiride, metformin, and pioglitazone—three distinct antidiabetic agents. This triple therapy offers enhanced blood glucose management when monotherapy or dual-drug regimens prove insufficient. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion to reduce blood sugar. Metformin, a biguanide, acts by reducing hepatic glucose production, slowing intestinal glucose absorption, and improving insulin responsiveness. Pioglitazone, a thiazolidinedione, further enhances insulin sensitivity.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent alcohol and Glimitoss MP 1mg/500mg/15mg SR Tablet ingestion is unsafe.
PregnancyCONSULT YOUR DOCTOR
The use of Glimitoss MP 1mg/500mg/15mg SR tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the potential benefits against any risks prior to prescription. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Prolonged-release Glimitoss MP tablets (1mg/500mg/15mg) are likely unsafe for breastfeeding mothers. Available human evidence indicates potential transfer to breast milk, posing a risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar imbalances.
KidneyCAUTION
Patients with kidney impairment should use Glimitoss MP 1mg/500mg/15mg SR tablets cautiously, potentially requiring dosage modification. Medical advice is essential. Glimitoss MP 1mg/500mg/15mg SR tablets are contraindicated in those with severe kidney disease. Regular kidney function monitoring is recommended during treatment.
LiverCAUTION
Patients with liver impairment should exercise caution when taking Glimitoss MP 1mg/500mg/15mg SR tablets, as dose modification may be necessary. Individuals with severe hepatic dysfunction should avoid this medication. A physician's guidance is recommended.
What if you forget to take Glimitoss MP 1mg/500mg/15mg Tablet SR :
Should you forget to take your Glimitoss MP 1mg/500mg/15mg SR Tablet, administer it at your earliest convenience. However, if your next scheduled dose is imminent, omit the missed dose and resume your usual medication routine. Never take a double dose.
Facts to Know About Glimitoss MP 1mg/500mg/15mg Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
3,018 People bought this recently